Watchlist Price Alert

Eledon Pharmaceuticals In... (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

2.69

-0.06 (-2.18%)

At close: Jun 27, 2025, 3:59 PM

2.69

0.19%

After-hours: Jun 27, 2025, 05:50 PM EDT

-2.18% (1D)

Bid	2.65
Market Cap	160.78M
Revenue (ttm)	192K
Net Income (ttm)	-19.05M
EPS (ttm)	-0.04
PE Ratio (ttm)	-67.12
Forward PE	-2.73
Analyst	Buy

Ask	2.85
Volume	599,134
Avg. Volume (20D)	216,132
Open	2.75
Previous Close	2.75
Day's Range	2.61 - 2.79
52-Week Range	2.30 - 5.54
Beta	-0.13

About ELDN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ELDN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ELDN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

7 months ago

-11.41%

Eledon Pharmaceuticals shares are trading lower af... Unlock content with Pro Subscription

News

1 month ago · zacks.com

What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock

Eledon Pharmaceuticals (ELDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 month ago · seekingalpha.com

Eledon: A Company With Good Early Data In Kidney Transplant Rejection And A Full Balance Sheet

Eledon Pharmaceuticals' lead candidate, tegoprubart, shows promise in improving kidney function post-transplant, potentially becoming the new standard-of-care over tacrolimus. With a significant total...